Ann coming $3, page-20

Not much chatter about it but my two cents regarding the presentation in NY:
1. The company is on track to deliver something this year....
2. The results from cohort B aren’t imminent but are likely a few months away. (I believe this is what Mr ‘situation critical’ is alerting us to with the huge dump of shares...........)
3. Cellularity MOU is a long way from any announcement. As Ross said, they are just discussing possibilities, no money talk as yet
4. They are in constant chatter with Fuji regarding GVHD trial and ross “hopes” Fuji will execute the license.
5. No mention of asthma.